MINI SHORT - ZEALAND PHARMA Share Price

Certificat

MINI S ZEAL AVA

GB00BQRM3X42

Market Closed - Nasdaq Stockholm
- ^SEK	-.--%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ZEALAND PHARMA A/S

Latest news about ZEALAND PHARMA A/S

Zealand Pharma Secures EU Panel Backing for Severe Hypoglycemia Treatment	31/05	MT
Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European Medicines Agency	31/05	GL
Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European Medicines Agency	31/05	AQ
Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024	29/05	GL

More news

Static data

Product type	Certificat Turbo Stop Loss
Buy / Sell	PUT
Underlying	ZEALAND PHARMA A/S
Issuer	Morgan Stanley
	MINI S ZEAL AVA
ISIN	GB00BQRM3X42
Date issued	11/03/2024
Strike	993.3 kr
Maturity	Unlimited
Parity	10 : 1
Emission price	- kr
Emission volume	N/A
Settlement	règlement en espèces
Currency	SEK

Technical Indicators

Spread	1.15 kr
Spread %	2.09%

Company Profile

Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2022, the Group had a portfolio of 7 products in clinical development (including 2 in phase III, 3 in phase II and 2 in phase I), and 4 products in preclinical development.

Sector

More about the company